In ER+ and/or PR+ BC with high Ki-67 (≥ 14%), the miRNA level was significantly lower in tumor tissues with high PR expression (scores of 6–8) than in tissues of patients with lower receptor expression. The gene discussed is MKI67; the disease is breast cancer.